Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Fayuvi

Pharmaceutical Executive Daily: FDA Approves Fayuvi

Published 2 months ago
Description
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us